Bochum, Germany

Soren Gatermann

This inventor holds 1 USPTO granted patent. Top assignees: Forschungszentrum Borstel, Ruhr-Universitat Bochum. Active years: 2018.


Average Co-Inventor Count = 14.0

ph-index = 1


Company Filing History:


Years Active: 2018

Loading Chart...
1 patent (USPTO):Explore Patents

Title: **Soren Gatermann: Innovator in Pharmaceutical Composition**

Introduction

Soren Gatermann is an accomplished inventor based in Bochum, Germany. With a focus on pharmaceutical compositions, Gatermann has made significant contributions to the field, particularly in the area of allergies and inflammatory disorders. His inventive spirit and dedication to research have led to the development of innovative solutions aimed at improving health outcomes.

Latest Patents

Gatermann holds a patent for a pharmaceutical composition designed for the protection against allergies and inflammatory disorders. This composition includes naturally occurring, non-transgenic isolated bacteria or fragments thereof, which serves as a medicament for the prevention and/or treatment of allergic or chronic inflammatory disorders. The process of producing this composition is also included in his patent, highlighting his commitment to advancing medical science.

Career Highlights

Throughout his career, Soren Gatermann has worked at notable institutions, including the Forschungszentrum Borstel and Ruhr-Universität Bochum. These positions have allowed him to engage in impactful research and contribute to the scientific community's understanding of health-related issues.

Collaborations

In his professional journey, Gatermann has collaborated with esteemed colleagues such as Albrecht Bufe and Otto Holst. These partnerships have fostered a productive environment for innovation and have furthered the development of groundbreaking pharmaceutical solutions.

Conclusion

Soren Gatermann's contributions to the field of pharmaceuticals underscore the importance of continuous innovation in addressing health challenges. His patent represents a significant step forward in the prevention and treatment of allergic and inflammatory conditions, reflecting his commitment to improving patient care and health outcomes through scientific research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…